Pazopanib

From IDWiki
  • Tyrosine kinase inhibitor
  • Inhibits multiple targets, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), c-KIT, and FGFR
  • Indicated for renal cell carcinoma and soft tissue sarcoma